Navigation Links
H3 Biomedicine and BGI Announce Collaboration to Develop and Share Crucial Cancer Genomic Sequencing Data
Date:3/21/2013

ng the lives of patients. H3 Biomedicine is based in Cambridge, Massachusetts. Visit http://www.H3biomedicine.com for more information.

About BGI
BGI was founded in Beijing, China, in 1999 with the mission to become a premier scientific partner for the global research community. The goal of BGI is to make leading-edge genomic science highly accessible, which it achieves through its investment in infrastructure, leveraging the best available technology, economies of scale, and expert bioinformatics resources. BGI, which includes both private non-profit genomic research institutes and sequencing application commercial units, and its affiliates, BGI Americas, headquartered in Cambridge, MA, and BGI Europe, headquartered in Copenhagen, Denmark, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental, and related applications.

BGI has a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high-profile research: research that has generated over 200 publications in top-tier journals such as Nature and Science. BGI's many accomplishments include: sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the International Human HapMap Project, carrying out research to combat SARS and German deadly E.coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome, and, more recently, the human Gut Metagenome, as well as a significant proportion of the genomes for the1000 Genomes Project.

'/>"/>
SOURCE H3 Biomedicine Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
2. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
3. Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia
4. Elbit Imaging Announces Receipt of an Acceleration Notice from Bank Leumi
5. Hologic Announces Completion of Loan Repricing
6. Meridian Health Plan Announces New Pharmacy Benefit Manager
7. GS Medical USA announces FY2012 record year-end sales growth of over 130% over FY2011
8. ENCO Pharmaceutical Development Announces Another Successful FDA Inspection - Its 2nd This Year
9. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
10. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
11. EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
(Date:8/28/2014)... Telik, Inc. (OTCQB: TELK), a clinical ... MabVax Therapeutics, Inc. on July 8, 2014, announced ... the development of its lead antibody program designated ... Company,s internally developed antibody discovery platform.  These preclinical ... based therapeutic and diagnostic products based on this ...
(Date:8/28/2014)... 2014  Rx Safes, Inc., the manufacturer of fingerprint ... waging a new war on drugs to reduce prescription ... More than 2,500 children a day experiment with ... are easily accessed from unsecured medicine cabinets, closets and drawers. ... streets, Rx Safes will address the new age drug ...
Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4Rx Safes, Inc. Announces New War On Drugs 2
... NOVI, Mich., Jan. 10, 2011 Nopras ... firm which specializes in services for organizations in ... regulated industries announced on January 10th, 2011 that ... Nopras Technologies, well documented procedures and ...
... N.J., Jan. 10, 2011 MedAvante, Inc., the ... central nervous system (CNS) disorders, announced the appointment ... position of Vice President, Neurocognition.  Dr. Randolph will ... experts and experienced, calibrated clinicians focusing on Alzheimer,s ...
Cached Medicine Technology:Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification 2MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area 2MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area 3
(Date:8/28/2014)... To kick off the fall season ... One Spas retailers across the country are offering 0% ... The Hot Tub Tailgate Event is from August 29th-September ... more information and to apply early! , As the ... wide variety of outdoor hot tubs with exclusive features ...
(Date:8/28/2014)... Somerset, N.J. (PRWEB) August 28, 2014 ... of advanced delivery technologies and development solutions for ... that Kristen DeVito, Global Director Clinical Supply Services, ... will present “Critical Path Sourcing Strategies for Active ... Trials Supply Conference, which takes place on the ...
(Date:8/28/2014)... nasal septum cells. Researchers at the University and the ... the nasal septum are able to adapt to the ... articular cartilage defects. The nasal cartilage cells, ability to ... with the expression of so-called HOX genes. The scientific ... research results together with the report of the first ...
(Date:8/28/2014)... who identify themselves as ,old, feel worse about their ... lower value than younger age groups. , New research ... old and ill, across different countries: social status, age ... the European Social Survey. Respondents, who were all aged ... The researchers found that those living in societies where ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 BCC Research ... SURGICAL NAVIGATION SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , the ... $419.7 million in 2013. Driven by the need for ... medical tourism in emerging geographies, the market is expected ... growth rate (CAGR) of 8.5% from 2013 through 2018. ...
Breaking Medicine News(10 mins):Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3
... In order to expand the range and reach of its affiliate ... Network this February. This is in addition to the company,s already ... ... Diego, CA (PRWEB) March 26, 2009 -- In order to expand ...
... a protein that helps prevent tumours spreading and growing ... many different types of cancer. In a study published ... , Canadian researchers modified the tumour inhibiting protein, von ... growth in mice. , When solid tumours grow they ...
... March 25 While dollars for infrastructure and construction ... becoming known that nearly $22 billion in stimulus funds ... across the nation. As the federal government works to ... Reinvestment Act of 2009 will be allocated, ...
... The U.S. Agency for International Development,s (USAID) ... providing more than $3.7 million in assistance to ... of families in Senegal.Of this $3.7 million, USAID ... efforts and agriculture production in the regions of ...
... The California Transplant Donor Network today issued the following statement on ... the line of duty: "Our hearts go out to the family ... community. Officer Hege was registered on the Donate Life California ... chose in death as he did in life to help those ...
... Demonstration on Anakam,s Authentication SolutionsSAN DIEGO, March 25 Anakam,s ... John Macaulay will be giving a presentation on two-factor authentication ... Place. The presentation will take place at 4:15 p.m. ... discussing issues healthcare faces in the age of electronic health ...
Cached Medicine News:Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 2Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 3Health News:Bioengineered proteins: Trial confirms new way to tackle cancer 2Health News:GlobalMedia Provides Free Grant Writing and Application Assistance to Healthcare Providers and Professionals Seeking Their Share of Billions in Economic Stimulus Dollars 2Health News:California Transplant Donor Network Issues Statement on Officer John Hege's Donation 2Health News:Dr. William 'Bill' Braithwaite and Dr. John Macaulay Present Anakam's Two-Factor Authentication Platform at HIMSS 2009 Annual Conference and Exhibition 2
BETADINE Solution Swab Aid antiseptic pads are for quick and easy skin degerming. Individually wrapped pads, saturated with 10% povidone-iodine solution, offer the advantages of BETADINE Solution in ...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
Medicine Products: